07 February 2025 : Clinical Research
Impact of Osteopathic Techniques on Autonomic Regulation: A Study of Heart Rate Variability in Healthy Adults
Jakub Stępnik ABCDEFG 1,2*, Agnieszka KędraDOI: 10.12659/MSM.946903
Med Sci Monit 2025; 31:e946903
Table 5 Results of the analysis of variance for the HRV parameter.
| HRV | Group | M | SE | 95% confidence interval | ANOVA | |
|---|---|---|---|---|---|---|
| Lower limit | Upper limit | |||||
| HRV I | CV4 | 0.09 | 0.01 | 0.07 | 0.11 | F1=(2,194)=0.712;p=0.492; eta2=0.003 |
| CV4+RR | 0.11 | 0.01 | 0.09 | 0.13 | ||
| Placebo | 0.11 | 0.01 | 0.09 | 0.12 | ||
| HRV II | CV4 | 0.11 | 0.01 | 0.09 | 0.12 | F2=(4,194)=0.609;p=0.657; eta2=0.005 |
| CV4+RR | 0.11 | 0.01 | 0.09 | 0.13 | ||
| Placebo | 0.11 | 0.01 | 0.09 | 0.13 | ||
| HRV III | CV4 | 0.10 | 0.01 | 0.08 | 0.12 | F3=(2,97)=0.857;p=0.427; eta2=0.011 |
| CV4+RR | 0.10 | 0.01 | 0.08 | 0.12 | ||
| Placebo | 0.11 | 0.01 | 0.09 | 0.13 | ||
| M – mean; SE – standard error; F1 – main effect of the HRV parameter; F2 – interaction effect between changes in HRV measurements and group; F3 – main effect of group; p – level of significance; eta2 – effect size. | ||||||






